One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Remission is the ambition: can remission rates for new patients with rheumatoid arthritis finally be improved, at minimal cost?
doi : 10.1093/rheumatology/keaf130
Rheumatology, Volume 64, Issue 7, July 2025, Pages 4107–4109
Challenges in the diagnosis and management of psoriatic arthritis in people of colour Free
The state of data sharing in rheumatology: a systematic review of top journal practices
A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis
From awareness to action: poor knowledge of physical activity correlates with lower activity and worse disease in axial spondyloarthritis
Active disease, fibromyalgia and exposure to glucocorticoids differentially associate with sleep and circadian parameters in Behçet’s syndrome
Cardiac MRI optimizes risk stratification accuracy in connective tissue disease-associated pulmonary arterial hypertension: a retrospective cohort study
Gout incidence in metformin versus sodium–glucose co-transporter-2 inhibitor users: a retrospective cohort study Open Access
Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis
Association of oral opioid usage and mortality in patients with inflammatory arthritides: a Korean nationwide cohort study
Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial Open Access
Do MRI-detected erosions in the RA-risk phase of arthralgia reflect current or imminent radiographic erosions? A large longitudinal imaging study Open Access
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort
Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre
Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data
Using a smartphone app to monitor Raynaud’s attacks and quantify skin colour changes—towards objective outcome measures for Raynaud’s Open Access
Risk factors of digital gangrene secondary to systemic lupus erythematosus flare: real-world data from 2014 to 2022
Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials
Physical activity in relation to the risk of systemic lupus erythematosus: a prospective study including 401Â 745 individuals
How have the clinical, laboratory, treatment features and outcomes in children with lupus nephritis progressed over the last 30 years? Open Access
Immunosuppressant withdrawal versus glucocorticoid withdrawal in SLE: 2-year outcomes of a noninferiority randomized controlled trial
Right atrial reservoir strain as an early predictor of pulmonary hypertension development in systemic sclerosis: a single-centre pilot study
Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study Open Access
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study
Male fertility is preserved following ixekizumab treatment—a real-life pilot study Free
Pulmonary involvement in systemic sclerosis: can sex play a role?
Insights into the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: findings from a cohort of 205 patients with primary APS Open Access
Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service delivery Open Access
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease Open Access
Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training
Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus
Cut-off matters in the interpretation of myositis antibodies by line immunoassay
Vamorolone: a novel metabolism resistant steroid that suppresses joint destruction in chronic polyarthritis with reduced systemic side effects Open Access
Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis Open Access
Diminished SUV3 expression and its functional implications in the IFN-enriched monocyte subset of childhood Sjögren’s disease
Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren’s disease
Correction to: Sustained drug-free remission in giant cell arteritis Free
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis Open Access
Sensitivity and specificity of optical coherence tomography retinal imaging within a giant cell arteritis fast track clinic
Relapse of mixed cryoglobulinemia despite sustained virologic response with nucleotide analogues therapy in chronic hepatitis B
Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL-17 treatment: a clinical case Open Access
New X for VEXAS: haploidentical allogeneic haematopoietic cell transplantation in VEXAS syndrome
Long-term outcomes in lung transplant for anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody positive interstitial lung disease: a case series Open Access
Comment on: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis
Comment on: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis: reply
Comment on: Associations between loneliness, disease activity, and disease impact in inflammatory arthritis: a nationwide cross-sectional study among more than 12 000 patients
Comment on: Associations between loneliness, disease activity and disease impact in inflammatory arthritis: a nationwide cross-sectional study among more than 12 000 patients: reply
Comment on: Impact of baseline proteinuria level on long-term outcomes in lupus nephritis
Comment on: Impact of baseline proteinuria level on long-term outcomes in lupus nephritis: reply
Comment on: ‘ANA-positive versus ANA-negative antiphospholipid antibody-positive patients: results from the APS ACTION Registry’
Comment on ‘ANA-positive versus ANA-negative antiphospholipid antibody-positive patients: results from the APS ACTION Registry’. Reply
Comment on: In clinical hand osteoarthritis research, self-reported pain questionnaires do not reflect the patient experience
Comment on: In clinical hand osteoarthritis research, self-reported pain questionnaires do not reflect the patient experience: reply Open Access
